« Back to Record
Massaro, F., Meuleman, N., Bron, D., Vercruyssen, M., & Maerevoet, M. (2022). Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis. Cancers (Basel), 14(4), 982. doi:10.3390/cancers14040982
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/341591



